核糖体S6激酶4在胰腺癌组织中的表达及其对预后评估的价值-现代医学

核糖体S6激酶4在胰腺癌组织中的表达及其对预后评估的价值

单位：1. 湖北省谷城人民医院检验科, 湖北谷城 441700;
2. 武汉大学中南医院检验科, 湖北武汉 430040

分类号：R735.9

出版年·卷·期（页码）：2017·36·第三期（439-443）

摘要：

目的：探讨核糖体S6激酶4（RSK4）在胰腺癌组织中的表达及其对预后评估的价值。方法：收集2012年4月至2013年4月湖北省谷城人民医院收治的72例胰腺癌患者的临床资料，采用免疫组化法检测胰腺癌组织和癌旁组织RSK4蛋白表达；以患者性别、年龄、糖尿病史、肿瘤发病部位、肿瘤分化程度、淋巴结转移、临床分期等作为观察指标，分析RSK4蛋白与临床资料的关系；再以肿瘤中位生存期作为观察指标，筛选影响胰腺癌患者预后的危险因素。结果：胰腺癌组织RSK4蛋白阳性表达率为23.6%（17/72），癌旁组织RSK4蛋白阳性表达率为52.8%（38/72），胰腺癌组织RSK4蛋白阳性表达率显著低于癌旁组织（χ²=12.973，P=0.000）。中、低分化胰腺癌组RSK4蛋白阳性率显著低于高分化胰腺癌组（P<0.05），有淋巴结转移组RSK4蛋白阳性率显著低于无淋巴结转移组（P<0.05），Ⅲ～Ⅳ期组RSK4蛋白阳性率显著低于Ⅰ～Ⅱ期组（P<0.05）。单因素分析显示，RSK4蛋白阳性组中位生存时间显著低于阴性组，高分化组中位生存期显著低于中、低分化组，淋巴结转移组中位生存期显著低于无淋巴结转移组，Ⅲ～Ⅳ期组中位生存期显著低于Ⅰ～Ⅱ期组，各组间比较差异具有统计学意义（均P<0.05）。多因素分析显示，RSK4蛋白、肿瘤分化程度、淋巴结转移、临床分期是影响胰腺癌预后的独立危险因素（均P<0.05）。结论：RSK4蛋白在胰腺癌组织表达显著低于癌旁组织，RSK4蛋白阳性率越低患者预后越差，RSK4蛋白可以作为胰腺癌诊断及预后评估的指标之一。

Objective: To explore the expression level and prognosis evaluation value of ribosomal S6 kinase-4(RSK4) in pancreatic cancer. Methods:Clinical data of 72 cases of pancreatic cancer patients treated in Gucheng People's Hospital from April 2012 to April 2013 were selected, RSK4 protein expression level were detected by immunohistochemical assay in pancreatic cancer tissues and adjacent tissues,by patient sex, age, history of diabetes, tumor location, tumor differentiation, lymph node metastasis and clinical stage as observed index,the relationship between RSK4 protein and clinical data was analyzed.By the median survival time of the tumor as the observation index,the risk factors for the prognosis of patients with pancreatic cancer were screened. Results: The positive expression rate of RSK4 protein in pancreatic cancer tissue was 23.6%(17/72), and the positive expression rate of RSK4 protein in paracancerous tissues was 52.8%(38/72),the positive expression rate of RSK4 protein in pancreatic cancer tissue was significantly lower than that in paracancerous tissues(χ²=12.973,P=0.000).In poorly differentiated pancreatic cancer group RSK4 protein positive rate was significantly lower than that in well differentiated pancreatic cancer group(P<0.05), in lymph node metastasis group RSK4 protein positive rate was significantly lower than that in without lymph node metastasis group(P<0.05),in Ⅲ～Ⅳ grade group RSK4 protein positive rate was significantly lower than that of Ⅰ～Ⅱ grade group(P<0.05).Single factor analysis showed that RSK4 protein in positive group was significantly lower than that in the negative group, the median survival in high differentiation group was significantly lower than that in the middle and low differentiation group, the median survival time of lymph node metastasis group was significantly lower than that of without lymph node metastasis group,and the median survival time in Ⅲ～Ⅳ grade group was significantly lower than that in the Ⅰ～Ⅱ grade group,the differences between each groups with statistically significant(all P<0.05).Multivariate analysis showed that RSK4 protein, tumor differentiation, lymph node metastasis and clinical stage were independent risk factors that influenced the prognosis of pancreatic cancer(all P<0.05). Conclusion:The expression of RSK4 protein in pancreatic cancer tissue is significantly lower than that in adjacent tissues,the lower the positive rate of RSK4 protein is, the worse prognosis in pancreatic cancer is.RSK4 protein can be used as one of the indicators for the diagnosis and prognosis of pancreatic cancer.

参考文献：

[1] ESER S, MESSER M, ESER P,et al.In vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging[J].Proc Natl Acad Sci U S A, 2011,108(24):9945-9950.
[2] 王凯,石欣,黄毅,等. 肿瘤标志物对胰腺癌诊断的研究进展[J].东南大学学报:医学版,2011,30(5):793-796.
[3] 周旻,王彩莲,余卫平. 胰腺癌中ETS1与血管生成的研究进展[J].东南大学学报:医学版,2013,28(4):496-500.
[4] ARUNKUMAR E,ANURADHA C V.Genistein promotes insulin action through adenosine monophosphate-activated protein kinase activation and p70 ribosomal protein S6 kinase 1 inhibition in the skeletal muscle of mice fed a high energy diet[J].Nutr Res, 2012,32(8):617-625.
[5] DEREWENDA U, ARTAMONOV M, SZUKALSKA G,et al.Identification of quercitrin as an inhibitor of the p90 S6 ribosomal kinase(RSK): structure of its complex with the N-terminal domain of RSK2 at 1.8 Åresolution[J].Acta Crystallogr D Biol Crystallogr, 2013,69(2):266-275.
[6] MODY N, AGOUNI A, MCILROY G D,et al.Susceptibility to diet-induced obesity and glucose intolerance in the APP(SWE)/PSEN1(A246E) mouse model of Alzheimer's disease is associated with increased brain levels of protein tyrosine phosphatase 1B(PTP1B) and retinol-binding protein 4(RBP4), and basal phosphorylation of S6 ribosomal protein[J].Diabetologia, 2011,54(8):2143-2151.
[7] THURET R, SUN M, ABDOLLAH F,et al.Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma[J].J Urol, 2011,185(2):501-507.
[8] CAO D, VOLLMER R T, LULY J,et al.Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma[J].Urology, 2010,76(3):593-599.
[9] 陈万青,郑荣寿,曾红梅,等.2011年中国恶性肿瘤发病和死亡分析[J].中国肿瘤,2015,24(1):1-10.
[10] KONDO S, UENO H, HOSOI H,et al.Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma[J].Br J Cancer, 2013,109(3):739-746.
[11] 杨华伟,刘剑仑,廖德仲,等.RSK4过表达真核表达载体对人乳腺癌移植瘤体内侵袭和转移的影响[J].中华医学杂志,2012,92(26):1845-1848.
[12] 张晓丽,刘剑仑,杨华伟,等.高与低表达RSK4基因人乳腺癌细胞株的筛选及鉴定[J].中华肿瘤防治杂志,2011,18(8):561-563,574.
[13] PARK Y S, CHO N J.EGFR and PKC are involved in the activation of ERK1/2 and p90 RSK and the subsequent proliferation of SNU-407 colon cancer cells by muscarinic acetylcholine receptors[J].Mol Cell Biochem, 2012,370(1-2):191-198.
[14] AMIRAK E, FULLER S J, SUGDEN P H,et al.p90 Ribosomal S6 kinases play a significant role in early gene regulation in the cardiomyocyte response to G(q)-protein-coupled receptor stimuli, endothelin-1 and alpha(1)-adrenergic receptor agonists[J].Biochem J, 2013,450(2):351-363.
[15] MAGNUSON B, EKIM B, FINGAR D C.Regulation and function of ribosomal protein S6 kinase(S6K) within mTOR signalling networks[J].Biochem J, 2012,441(1):1-21.
[16] SHIN S, WOLGAMOTT L, YU Y,et al.Glycogen synthase kinase(GSK)-3 promotes p70 ribosomal protein S6 kinase(p70S6K) activity and cell proliferation[J].Proc Natl Acad Sci U S A, 2011,108(47):E1204-1213.
[17] 蔡君,张涛.RSK4蛋白在结直肠癌中的表达及临床意义[J].肿瘤学杂志,2015,21(3):252-254.
[18] WOJTALLA A, FISCHER B, KOTELEVETS N,et al.Targeting the phosphoinositide 3-kinase p110-α isoform impairs cell proliferation, survival, and tumor growth in small cell lung cancer[J].Clin Cancer Res, 2013,19(1):96-105.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录